Recruiting

TEPSeUltrasound-Assisted Psoas Tenotomy for Ilio-Psoas Conflict After Hip Replacement

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

The study evaluates the success rate of using ultrasound-assisted psoas tenotomy to relieve ilio-psoas conflict in patients who have had hip replacement surgery.

What is being tested

Psoas tenotomy under ultrasound

Procedure
Who is being recruted

Wounds and Injuries

+ Hip Injuries

Over 18 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: December 2025
See protocol details

Summary

Principal SponsorCentre Hospitalier Universitaire de Nice
Study ContactGrégoire MICICOI
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: December 1, 2025

Actual date on which the first participant was enrolled.

The study focuses on finding a new way to relieve pain in people who experience discomfort after having a hip replacement. This discomfort often occurs due to a clash between the hip implant and a tendon in the body called the ilio-psoas tendon. The traditional method to relieve this pain is a procedure called psoas tenotomy, which involves cutting the tendon to ease the tension. However, this study explores the use of ultrasound technology to perform this procedure, which might offer a less invasive option with quicker recovery and fewer complications. This new method could significantly enhance the comfort and mobility of those suffering from this post-surgery complication. In this study, participants who have pain after a hip replacement due to ilio-psoas conflict will undergo an ultrasound-assisted psoas tenotomy. Instead of using more complex surgical equipment, this technique uses ultrasound to guide the procedure, which might lead to less scarring and a quicker surgical process. The study will evaluate how well this approach works by measuring pain relief and improvements in movement and function after the procedure. This could provide a safer and more efficient option for patients, potentially leading to better overall outcomes in their recovery process.

Official TitlePsoas Tenotomy Under Ultrasound
NCT06064136
Principal SponsorCentre Hospitalier Universitaire de Nice
Study ContactGrégoire MICICOI
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

15 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Wounds and InjuriesHip Injuries

Criteria

4 inclusion criteria required to participate
Indication of psoas tenotomy for ilio-psoas conflict after total hip replacement

Patients 18 years of age or older

Signature of the written informed consent form by the patient

Affiliation to a French health insurance scheme or equivalent

5 exclusion criteria prevent from participating
Patient on anticoagulant or antiplatelet agents

Vulnerable people: pregnant or breast-feeding women (patients will undergo a pregnancy test: urinary test), adult under guardianship or deprived of freedom.

Allergies to local anesthetics

Contraindication to surgery

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Nice University Hospital

Nice, FranceOpen Nice University Hospital in Google Maps
Recruiting
One Study Center